Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Cell Line Generation Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4529948
    • |
  • 20 April, 2023
    • |
  • Global
    • |
  • 110 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Medical Devices & Consumables

Cell line generation (CLG) in the scope of bioproduction can be defined as a method to isolate a single cell expressing a recombinant protein of interest.
According to our (Global Info Research) latest study, the global Cell Line Generation market size was valued at USD 1727 million in 2022 and is forecast to a readjusted size of USD 3264.4 million by 2029 with a CAGR of 9.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of cell line generation include Boehringer Ingelheim BioXcellence, Lonza, WuXi Biologics, Thermo Fisher Scientific, etc. Global top five manufacturers hold a share over 39%. In terms of product, knockout cell lines are the largest segment, with a share over 49%. And in terms of application, the largest application is pharmaceutical industry, with a share over 70%.
This report is a detailed and comprehensive analysis for global Cell Line Generation market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cell Line Generation market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cell Line Generation market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cell Line Generation market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cell Line Generation market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell Line Generation
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell Line Generation market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim BioXcellence, Lonza, WuXi Biologics, Thermo Fisher Scientific and Sartorius, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cell Line Generation market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Knockout Cell Lines
Overexpression Cell Lines
Inducible Expression Cell Lines
Knockdown Cell Lines
Knockin Cell Lines
Others
Market segment by Application
Pharmaceutical Industry
Biological Industry
Market segment by players, this report covers
Boehringer Ingelheim BioXcellence
Lonza
WuXi Biologics
Thermo Fisher Scientific
Sartorius
Merck
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Porton Biologics
Chempartner Pharmatech
Rentschler Biopharma
ProBioGen
AGC Biologics
OPM Biosciences
Charles River Laboratories
Mycenax Biotech
JOINN Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell Line Generation product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell Line Generation, with revenue, gross margin and global market share of Cell Line Generation from 2018 to 2023.
Chapter 3, the Cell Line Generation competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell Line Generation market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell Line Generation.
Chapter 13, to describe Cell Line Generation research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Cell Line Generation
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cell Line Generation by Type
    • 1.3.1 Overview: Global Cell Line Generation Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Cell Line Generation Consumption Value Market Share by Type in 2022
    • 1.3.3 Knockout Cell Lines
    • 1.3.4 Overexpression Cell Lines
    • 1.3.5 Inducible Expression Cell Lines
    • 1.3.6 Knockdown Cell Lines
    • 1.3.7 Knockin Cell Lines
    • 1.3.8 Others
  • 1.4 Global Cell Line Generation Market by Application
    • 1.4.1 Overview: Global Cell Line Generation Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Pharmaceutical Industry
    • 1.4.3 Biological Industry
  • 1.5 Global Cell Line Generation Market Size & Forecast
  • 1.6 Global Cell Line Generation Market Size and Forecast by Region
    • 1.6.1 Global Cell Line Generation Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Cell Line Generation Market Size by Region, (2018-2029)
    • 1.6.3 North America Cell Line Generation Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Cell Line Generation Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Cell Line Generation Market Size and Prospect (2018-2029)
    • 1.6.6 South America Cell Line Generation Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Cell Line Generation Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Boehringer Ingelheim BioXcellence
    • 2.1.1 Boehringer Ingelheim BioXcellence Details
    • 2.1.2 Boehringer Ingelheim BioXcellence Major Business
    • 2.1.3 Boehringer Ingelheim BioXcellence Cell Line Generation Product and Solutions
    • 2.1.4 Boehringer Ingelheim BioXcellence Cell Line Generation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Boehringer Ingelheim BioXcellence Recent Developments and Future Plans
  • 2.2 Lonza
    • 2.2.1 Lonza Details
    • 2.2.2 Lonza Major Business
    • 2.2.3 Lonza Cell Line Generation Product and Solutions
    • 2.2.4 Lonza Cell Line Generation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Lonza Recent Developments and Future Plans
  • 2.3 WuXi Biologics
    • 2.3.1 WuXi Biologics Details
    • 2.3.2 WuXi Biologics Major Business
    • 2.3.3 WuXi Biologics Cell Line Generation Product and Solutions
    • 2.3.4 WuXi Biologics Cell Line Generation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 WuXi Biologics Recent Developments and Future Plans
  • 2.4 Thermo Fisher Scientific
    • 2.4.1 Thermo Fisher Scientific Details
    • 2.4.2 Thermo Fisher Scientific Major Business
    • 2.4.3 Thermo Fisher Scientific Cell Line Generation Product and Solutions
    • 2.4.4 Thermo Fisher Scientific Cell Line Generation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.5 Sartorius
    • 2.5.1 Sartorius Details
    • 2.5.2 Sartorius Major Business
    • 2.5.3 Sartorius Cell Line Generation Product and Solutions
    • 2.5.4 Sartorius Cell Line Generation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Sartorius Recent Developments and Future Plans
  • 2.6 Merck
    • 2.6.1 Merck Details
    • 2.6.2 Merck Major Business
    • 2.6.3 Merck Cell Line Generation Product and Solutions
    • 2.6.4 Merck Cell Line Generation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Merck Recent Developments and Future Plans
  • 2.7 Catalent
    • 2.7.1 Catalent Details
    • 2.7.2 Catalent Major Business
    • 2.7.3 Catalent Cell Line Generation Product and Solutions
    • 2.7.4 Catalent Cell Line Generation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Catalent Recent Developments and Future Plans
  • 2.8 Samsung Biologics
    • 2.8.1 Samsung Biologics Details
    • 2.8.2 Samsung Biologics Major Business
    • 2.8.3 Samsung Biologics Cell Line Generation Product and Solutions
    • 2.8.4 Samsung Biologics Cell Line Generation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Samsung Biologics Recent Developments and Future Plans
  • 2.9 FUJIFILM Diosynth Biotechnologies
    • 2.9.1 FUJIFILM Diosynth Biotechnologies Details
    • 2.9.2 FUJIFILM Diosynth Biotechnologies Major Business
    • 2.9.3 FUJIFILM Diosynth Biotechnologies Cell Line Generation Product and Solutions
    • 2.9.4 FUJIFILM Diosynth Biotechnologies Cell Line Generation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
  • 2.10 Porton Biologics
    • 2.10.1 Porton Biologics Details
    • 2.10.2 Porton Biologics Major Business
    • 2.10.3 Porton Biologics Cell Line Generation Product and Solutions
    • 2.10.4 Porton Biologics Cell Line Generation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Porton Biologics Recent Developments and Future Plans
  • 2.11 Chempartner Pharmatech
    • 2.11.1 Chempartner Pharmatech Details
    • 2.11.2 Chempartner Pharmatech Major Business
    • 2.11.3 Chempartner Pharmatech Cell Line Generation Product and Solutions
    • 2.11.4 Chempartner Pharmatech Cell Line Generation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Chempartner Pharmatech Recent Developments and Future Plans
  • 2.12 Rentschler Biopharma
    • 2.12.1 Rentschler Biopharma Details
    • 2.12.2 Rentschler Biopharma Major Business
    • 2.12.3 Rentschler Biopharma Cell Line Generation Product and Solutions
    • 2.12.4 Rentschler Biopharma Cell Line Generation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Rentschler Biopharma Recent Developments and Future Plans
  • 2.13 ProBioGen
    • 2.13.1 ProBioGen Details
    • 2.13.2 ProBioGen Major Business
    • 2.13.3 ProBioGen Cell Line Generation Product and Solutions
    • 2.13.4 ProBioGen Cell Line Generation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 ProBioGen Recent Developments and Future Plans
  • 2.14 AGC Biologics
    • 2.14.1 AGC Biologics Details
    • 2.14.2 AGC Biologics Major Business
    • 2.14.3 AGC Biologics Cell Line Generation Product and Solutions
    • 2.14.4 AGC Biologics Cell Line Generation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 AGC Biologics Recent Developments and Future Plans
  • 2.15 OPM Biosciences
    • 2.15.1 OPM Biosciences Details
    • 2.15.2 OPM Biosciences Major Business
    • 2.15.3 OPM Biosciences Cell Line Generation Product and Solutions
    • 2.15.4 OPM Biosciences Cell Line Generation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 OPM Biosciences Recent Developments and Future Plans
  • 2.16 Charles River Laboratories
    • 2.16.1 Charles River Laboratories Details
    • 2.16.2 Charles River Laboratories Major Business
    • 2.16.3 Charles River Laboratories Cell Line Generation Product and Solutions
    • 2.16.4 Charles River Laboratories Cell Line Generation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Charles River Laboratories Recent Developments and Future Plans
  • 2.17 Mycenax Biotech
    • 2.17.1 Mycenax Biotech Details
    • 2.17.2 Mycenax Biotech Major Business
    • 2.17.3 Mycenax Biotech Cell Line Generation Product and Solutions
    • 2.17.4 Mycenax Biotech Cell Line Generation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Mycenax Biotech Recent Developments and Future Plans
  • 2.18 JOINN Laboratories
    • 2.18.1 JOINN Laboratories Details
    • 2.18.2 JOINN Laboratories Major Business
    • 2.18.3 JOINN Laboratories Cell Line Generation Product and Solutions
    • 2.18.4 JOINN Laboratories Cell Line Generation Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 JOINN Laboratories Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cell Line Generation Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Cell Line Generation by Company Revenue
    • 3.2.2 Top 3 Cell Line Generation Players Market Share in 2022
    • 3.2.3 Top 6 Cell Line Generation Players Market Share in 2022
  • 3.3 Cell Line Generation Market: Overall Company Footprint Analysis
    • 3.3.1 Cell Line Generation Market: Region Footprint
    • 3.3.2 Cell Line Generation Market: Company Product Type Footprint
    • 3.3.3 Cell Line Generation Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cell Line Generation Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Cell Line Generation Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Cell Line Generation Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Cell Line Generation Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Cell Line Generation Consumption Value by Type (2018-2029)
  • 6.2 North America Cell Line Generation Consumption Value by Application (2018-2029)
  • 6.3 North America Cell Line Generation Market Size by Country
    • 6.3.1 North America Cell Line Generation Consumption Value by Country (2018-2029)
    • 6.3.2 United States Cell Line Generation Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Cell Line Generation Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Cell Line Generation Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Cell Line Generation Consumption Value by Type (2018-2029)
  • 7.2 Europe Cell Line Generation Consumption Value by Application (2018-2029)
  • 7.3 Europe Cell Line Generation Market Size by Country
    • 7.3.1 Europe Cell Line Generation Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Cell Line Generation Market Size and Forecast (2018-2029)
    • 7.3.3 France Cell Line Generation Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Cell Line Generation Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Cell Line Generation Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Cell Line Generation Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cell Line Generation Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Cell Line Generation Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Cell Line Generation Market Size by Region
    • 8.3.1 Asia-Pacific Cell Line Generation Consumption Value by Region (2018-2029)
    • 8.3.2 China Cell Line Generation Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Cell Line Generation Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Cell Line Generation Market Size and Forecast (2018-2029)
    • 8.3.5 India Cell Line Generation Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Cell Line Generation Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Cell Line Generation Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Cell Line Generation Consumption Value by Type (2018-2029)
  • 9.2 South America Cell Line Generation Consumption Value by Application (2018-2029)
  • 9.3 South America Cell Line Generation Market Size by Country
    • 9.3.1 South America Cell Line Generation Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Cell Line Generation Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Cell Line Generation Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cell Line Generation Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Cell Line Generation Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Cell Line Generation Market Size by Country
    • 10.3.1 Middle East & Africa Cell Line Generation Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Cell Line Generation Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Cell Line Generation Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Cell Line Generation Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Cell Line Generation Market Drivers
  • 11.2 Cell Line Generation Market Restraints
  • 11.3 Cell Line Generation Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Cell Line Generation Industry Chain
  • 12.2 Cell Line Generation Upstream Analysis
  • 12.3 Cell Line Generation Midstream Analysis
  • 12.4 Cell Line Generation Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cell Line Generation. Industry analysis & Market Report on Cell Line Generation is a syndicated market report, published as Global Cell Line Generation Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Cell Line Generation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,735.28
    		4,102.92
    		5,470.56
    		3,215.52
    		4,823.28
    		6,431.04
    		544,898.40
    		817,347.60
    		1,089,796.80
    		289,849.20
    		434,773.80
    		579,698.40
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo